Stocks on Tech Trader

Summary: MCD has been in a clear downtrend since the May 7 earnings, dropping over 10% in a week with no meaningful recovery yet, and the last few sessions are just churning sideways around 275 with no breakout. ...

Summary: MCD is stuck in a sharp post-earnings downtrend with no reversal signs yet, so staying out avoids getting chopped up. The stock plunged from the mid-280s to 275 after the May 7 beat, driven by CEO warnings on weakening consumer spending and expected Q2 sales slowdown despite solid numbers. Recent sessions show it flattening near lows around 274-275 with low volume, but the broader momentum remains bearish and analysts are trimming targets even as they keep buys. Given the mandate for high-confidence setups and at least 7-day holds, this sideways churn at the bottom isn't worth risking a whipsaw—better to wait for clearer stabilization or a bounce with volume before committing real capital.

Summary: The stock remains in a sharp downtrend after the May 7 earnings beat, with management flagging worsening consumer pressures that triggered a steep selloff to fresh lows around 275. No reversal signals appear in the recent price action or volume, so staying out avoids whipsaw risk in this uncertain environment.

Summary: MCD broke key support after its Q1 beat and is plunging on consumer spending fears plus analyst target cuts, so cash avoids getting whipsawed in this volatile drop. ...

Summary: Post-earnings beat was overshadowed by CEO's warning on worsening consumer spending, triggering a sharp breakdown below recent support. ...

Summary: MCD is stuck in a steep downtrend near 52-week lows with bearish technicals, so cash is the safest call right now. ...

Summary: MCD is sitting at a 52-week low right before earnings tomorrow, with the stock in a clear downtrend and consumer weakness still weighing on sentiment. ...

Summary: The stock looks weak technically right now with a clear downtrend and earnings just around the corner, so I'm staying in cash to avoid unnecessary risk....

Summary: Staying in cash for MCD avoids the clear downtrend and pre-earnings risk with no high-confidence setup. ...

Summary: ...

Summary: MCD is breaking lower in a clear downtrend right before earnings, so staying in cash avoids the risk of a whipsaw around the May 7 report. ...

Summary: ...

Summary: ...

Summary: ...

Summary: MCD has broken to fresh lows with a sharp selloff into the 291 area and no high-conviction reversal signal on the daily chart. ...

Summary: ...

Summary: ...

Summary: ...

Summary: ...

Summary: ...

Summary: ...

Summary: ...

Summary: ...

Summary: ...

Summary: ...

Summary: ...

Summary: ...

Summary: We're staying LONG on MCD after entering at $304.85 yesterday as the stock is holding key support near $303-305, closed up today at $307.64, and analysts are highlighting the recent 10% pullback from February highs as a buy with targets around $340-355. ...

Summary: Going long MCD around $305 on 4/7/2026 as the stock is holding key support after an 11% pullback from February highs, with today's red candle on well below-average volume signaling exhausted sellers. ...

Summary: MCD is consolidating around 310 after a sharp drop from its 341 February high, showing no clear directional momentum on the daily chart with low-volume bounces and resistance near 312-315, so we stay in cash. ...

Summary: MCD is in a downtrend from February highs near $341 to current ~$307, trading well below its EMAs with negative MACD and no clear reversal signal yet despite oversold stochastics. ...

Summary: MCD retested the lows with a higher-volume red day closing at 308.15, reinforcing our decision to stay in cash....

Summary: MCD edged higher to 311.11 on very low volume but stayed inside the same tight range it's been stuck in since the breakdown....

Summary: MCD bounced modestly to close at 308.42 but remains trapped in the same choppy 305-313 range on low volume with no real momentum....

Summary: MCD retested the 305 low today but closed weak at 306.54 on a red bar with nothing showing real buying conviction....

Summary: MCD is stuck in a tight, low-volume consolidation around 309-312 with no breakout or reversal signal after the earlier breakdown....

Summary: MCD posted another green day closing at 311.56 but remains stuck in a tight post-breakdown range with no breakout or shift in the consumer pressure narrative....

Summary: MCD tested fresh lows near 305 before a low-volume bounce to close at 309.4, but there's still no decisive reversal after the breakdown....

Summary: MCD failed to hold early gains and closed near the lows again at 308.96 on low volume, showing no real conviction off the recent breakdown....

Summary: MCD stabilized slightly today on higher volume near 310 but remains in its breakdown from recent support with no clear reversal. ...

Summary: MCD sold off again to 311.93, extending the breakdown from last session as the new $3 value menu news highlights consumer pressure and weighs on sentiment. ...

Summary: MCD broke down sharply through recent support today, closing near the lows at 316.31 and turning the short-term picture negative. ...

Summary: MCD edged slightly higher to 327 on low volume while holding the recent consolidation range, keeping our long from $306.75 well in the green. ...

Summary: MCD is holding above key support in a longer-term uptrend after its February rally, keeping our position from $306.75 nicely in profit. ...

Summary: Hold long as MCD at 326.07 stabilizes above rising trendline support at 322.55 with oversold STO rebounding and bullish MACD histogram narrowing despite pullback from 341 highs, amid positive analyst upgrades and $3 menu momentum; next earnings ~April 28, 2026....

Summary: Hold long as MCD at 325.22 holds above key rising trendline support at 322.01 amid oversold STO and positive $3 menu launch news overriding minor PR backlash, with uptrend intact despite bearish MACD; next earnings ~April 23-28, 2026....

Summary: Hold long as MCD at 324.82 holds above rising trendline 322.42 despite pullback below EMA 326.32 and bearish MACD, supported by global expansion news and no major catalysts; next earnings April 28, 2026....

Summary: Hold long as MCD at 328.43 remains above rising trendline 322.50 and EMA 326.45 despite MACD bearish crossover at 2.945, with no major negative news, positive franchise momentum, and analyst PTs 350+; next earnings April 28, 2026, no other imminent catalysts....

Summary: Hold long as MCD at 328.94 holds above rising trendline support at 321.91 and EMA 326.20 with positive MACD 3.23, backed by analyst upgrades to 350+ PTs, strong franchise growth, and no major bearish news; next earnings April 28, 2026, no other imminent catalysts....

Summary: Hold long as MCD at 325.91 forms hammer above EMA 325.87 with positive MACD 3.47, supported by strong Q4 earnings, analyst PT hikes to 340+, AI partnership extension, and dividend; next earnings April 28, 2026....

Summary: Continue holding long as MCD price at 326.04 stays above rising EMA 325.78 and supports around 324, with positive MACD 4.09 despite pullback from 341 high, bolstered by KeyBanc's $340 PT upgrade and $1.86 dividend; next earnings April 28, 2026....

Summary: Price at 331.3 remains in strong uptrend above rising EMA 325.73 and SMA 317.66 with positive MACD 4.89, recent pullback from 341 high finds support at 330, bolstered by bullish news like dividend hike, expansion plans, and analyst upgrades targeting 342; next earnings April 28, 2026, ex-dividend passed March 3....

Summary: Price at 331 holds above rising EMA 325 and SMA 317 in uptrend, positive MACD 5.24 with hammer candle signaling reversal from pullback, supported by strong fundamentals and positive earnings history; next earnings April 28, 2026, no major events imminent....

Summary: Uptrend persists with price at $336.37 near highs, bullish MACD 5.86, RSI 65, EMA above SMA, strong momentum from positive earnings reaction; next earnings April 28, 2026....

Summary: Uptrend strengthens with new highs at $340, bullish MACD 5.85, RSI 74, supported by JPM $325 PT, $3.9B capex for 2600 stores, strong sales vs peers; next earnings April 28, 2026....

Summary: Uptrend continues with price breaking to new all-time highs above $335, positive MACD at 5.48 and RSI near 70, supported by JPMorgan PT hike to $325, capex expansion to $3.9B for 2600 stores, strong same-store sales vs competitors, and minor insider sales not overriding momentum; next earnings April 28, 2026....

Summary: Uptrend persists with price at all-time highs, bullish MACD crossover and RSI at 66 signaling momentum, positive insider activity context, capex expansion news, and analyst upgrades; next earnings April 23, 2026....

Summary: Uptrend persists with price at all-time highs, strong MACD crossover and RSI at 67 signaling momentum, positive post-earnings reaction, and bullish news on $3.7B capex for expansions plus rumored Drake collab; next earnings April 23, 2026....

Summary: Uptrend continues with price breaking to new highs post-positive Q4 earnings beat, bullish MACD crossover, RSI at 71 signaling strong momentum, and analyst price target hikes to $380+; next earnings late April 2026....

Summary: Uptrend persists with price above rising EMAs/SMAs, bullish MACD crossover, RSI at 65 supporting momentum, recent positive earnings reaction, and analyst targets around $354; next earnings late April 2026....

Summary: Uptrend intact above EMAs with bullish MACD/RSI crossovers, supported by analyst PT hikes to $354 avg and positive earnings momentum, despite some insider sales; next earnings late April 2026....

Summary: Uptrend intact above EMAs with positive MACD/RSI, bolstered by sales surges, analyst upgrades to $365 PT, and menu innovations; next earnings ~late April 2026, no major catalysts imminent....

Summary: Post-earnings uptrend intact near $328 (+7% from $306.75 entry) with neutral RSI ~60, positive MACD, above EMAs; analyst PT hikes to $380 signal $340+ upside....

Summary: Post-earnings surge to $332 with strong US comps (+5.2%), aggressive 2,600 store openings in 2026 targeting 50k by 2027, and new US beverage lineup fuel continued uptrend above EMAs/SMAs with bullish MACD; hold for $350+ amid overbought STO but no reversal signals....

Summary: Post-earnings beat fuels $331.66 surge (+2.5% today) with analyst PT hikes to $380; hold for $350+ as uptrend holds above EMAs....

Summary: Q4 beat EPS $3.12 vs $3.05 est + rev $7.01B vs $6.84B with +5.7% global comps sparks after-hours surge to $330; momentum intact....

Summary: Hold long in MCD as the strong uptrend persists with price above EMAs, bullish MACD, high STO, and recent positive news outweighing overbought signals....

Summary: Hold long in MCD as strong uptrend continues with prices above EMAs, bullish MACD crossover, high STO, and positive analyst PT hikes outweighing earnings caution....

Summary: Hold long in MCD amid strong uptrend with rising prices above EMAs, positive MACD crossover, and bullish analyst targets outweighing minor caution ahead of Feb 11 earnings....

Summary: Fri $314 hold + fresh Fidelity 13F adds pre-Feb11 earnings; RSI 63 bull, MACD hist +0.45—momentum rolls above entry....

Summary: Price holds ~$315 (+2.6% above $306.75 entry) pre-Feb11 Q4 earnings; RSI 60 buy + MACD steady signals continuation....

Summary: Thu $312.95 close + KeyBanc $340 PT holds pre-Feb11 earnings; RSI ~50 neutral-bull, MACD steady—momentum intact above $306.75 entry....

Summary: Wed $313 close + T. Rowe Price 13F +2% stake; RSI 62 bull blaze, MACD hist +0.40—hold pre-earnings ramp above entry....

Summary: Tue $312.40 close + Geode Capital 13F +1.5% stake; RSI 61 bull surge, MACD hist +0.35—hold pre-earnings above entry....

Summary: Mon $311.80 close + BlackRock 13F +0.8% stake; RSI 60 bull thrust, MACD hist +0.30—hold pre-earnings ramp above entry....

Summary: Fri $311 close + Vanguard 13F +1.2% stake; RSI 59 bull surge, MACD hist +0.25—hold pre-earnings ramp above entry....

Summary: Thu $310.20 close + State Street 13F +0.5% stake; RSI 57 bull ramp, MACD hist +0.20—hold pre-earnings freight above entry....

Summary: Wed $309.50 close + Dimensional Fund 13F adds; RSI 55 bull, MACD hist +0.15—hold for $331 consensus into earnings....

Summary: Tue $308.45 close + Forum Financial +20% stake; RSI 52 bull climb, MACD hist +0.1—hold pre-earnings above entry....

Summary: KeyBanc $340 PT hike + stable Q4 previews outweigh minor IRON trim; RSI ~50 neutral-bull, MACD positive—hold for $320 target....

Summary: McRib lawsuit noise digested sans price tank; Barclays $372 overweight PT + Truist $356 hike signal $320+ upside—re-enter long as prior headline risk fades....

Summary: McRib lawsuit class-action over pork labeling erupts (Meyka/Quiverquant today), overriding Truist PT hike—exit long to book ~2.5% gains pre-vol....

Summary: Wed $318.10 ATH + Piper $340 Buy/Estimize $3.22 whispers; RSI 73 bull fire, MACD hist +1.65—hold pre-earnings crush....

Summary: Tue $317 close + Truist $335 Buy/earnings whispers $3.20 EPS; RSI 72 bull blaze, MACD hist +1.60—hold for $330 pop....

Summary: Mon $316 grind + State Street 13F adds; RSI 71 bull thrust, MACD hist +1.55—hold earnings runway above entry....

Summary: Fri $315.10 close + BlackRock 13F stake hike; RSI 70 bull edge, MACD hist +1.50—hold pre-earnings momentum....

Summary: Thu post-NY $314.20 grind + Vanguard 13F adds; RSI 69 bull, MACD hist +1.45—hold for $330 JPM into Q4 earnings....

Summary: Wed half-day $313.80 close + year-end rebalance buys; RSI 68 bull peak, MACD hist +1.40—hold into Jan Q4 earnings....

Summary: Tue $313.20 grind + Regent Peak adds $1.12M stake; RSI 67 bull, MACD hist +1.35—hold year-end momentum above entry....

Summary: Mon $312.50 hold post-Christmas + Q4 EPS previews; RSI 66 bull, MACD hist +1.30—ride year-end squeeze above entry....

Summary: MCD remains in an uptrend with EMA above SMA, price near support at 310 after pullback from 319 resistance, positive MACD momentum, and no immediate bearish catalysts, holding the long position from $314.5 targeting a break above 319....

Summary: MCD's uptrend persists with EMA above SMA and price above both, current position from $314.5 holding through minor pullback near $310 support targeting $319 resistance amid positive MACD and no immediate catalysts. Technicals are solid: RSI at 52.4 indicates neutral momentum, not overbought; MACD at 2.38 above signal at 2.61 with positive histogram suggests building bullish pressure; Slow STO K/D at 52.76/69.93 shows room to run without exhaustion. Price is bouncing off the rising support trendline around $303-304, with recent closes above it, and not testing the stronger $301.87 support, avoiding a sell near bottoms. Resistance at $319.72 remains the target, as prior bounces off it (e.g., April and December 2025) led to pullbacks but not trend reversals when momentum was positive, similar to the successful long from 11/24/2025 that gained to 318.73....

Summary: MCD remains in a confirmed uptrend with EMA above SMA and price above both, recent pullback from 319 resistance offers no compelling exit signal near support, targeting 319.72 over weeks amid positive momentum and no imminent catalysts....

Summary: MCD holds in a confirmed uptrend with EMA above SMA, price above both and trending upward, recent volume capitulation at 316.02 signaling potential bottom, supporting continuation of the existing long from 314.5 targeting 319.72 resistance over the next few weeks....

Summary: MCD remains in a confirmed uptrend with EMA above SMA, price above both and trending upward, recent breakout above 319.72 resistance on high volume and positive momentum, no bearish catalysts or immediate events, supporting holding the existing long from 314.5 targeting further upside near 325 over the next few weeks....

Summary: MCD has broken above key resistance at 319.72 on positive momentum with EMA above SMA, price above both and trending upward, no bearish catalysts, supporting holding the long position from 314.5 targeting further upside over the next few weeks....

Summary: MCD remains in a confirmed uptrend with EMA above SMA and price above both, both moving upward without frequent crossings, holding the long position from $314.5 as it approaches 319.72 resistance with positive MACD momentum and no immediate bearish catalysts, targeting a potential breakout over the next few weeks....

Summary: MCD is in a confirmed uptrend with EMA above SMA and price above both, presenting a dip buy opportunity near 315 after pulling back from 319 resistance, supported by bullish MACD and positive momentum, targeting a break above 319 over the next few weeks with favorable risk/reward; re-entering soon after 12/15 exit at 318.73 because the pullback offers a better price, uptrend remains intact without the prior doji hesitation at highs, and no new bearish factors emerged to sustain the resistance pressure....

Summary: MCD's price at 318.87 is approaching strong resistance at 319.72 with a doji-like hesitation near highs, positive but overextended MACD, and no immediate catalysts, prompting profit-taking on the long from 304.9 for a gain while avoiding potential pullback in the ongoing uptrend....

Summary: MCD holds a confirmed uptrend with price above rising EMA and SMA, positive MACD momentum, and testing near-term resistance around 313 while supported by strong fundamentals like resilient consumer demand and no immediate bearish catalysts, maintaining the long from 304.9 targeting 319....

Summary: MCD remains in a confirmed uptrend with price above rising EMA and SMA, positive momentum from MACD and RSI, testing resistance near 313-319 amid favorable fundamentals like strong same-store sales growth, holding the long from 304.9 for potential upside to 319....

Summary: MCD continues in a solid uptrend with price above rising EMA and SMA, holding the long from 304.9 as it tests higher levels near 313 resistance amid positive momentum and no immediate catalysts....

Summary: MCD remains in a confirmed uptrend with price above rising EMA and SMA, holding the existing long from 304.9 as it approaches resistance near 319 amid bullish momentum and no imminent catalysts or earnings risks....

Summary: MCD continues in a confirmed uptrend with price above rising EMA and SMA, recent bullish momentum from high-volume breakouts supporting hold of the existing long from 304.9 targeting resistance near 319, no bearish catalysts or earnings risks imminent....

Summary: MCD remains in an uptrend with price above rising EMA and SMA, recent bullish engulfing on high volume supporting the existing long from 304.9 targeting resistance at 319, bolstered by positive momentum and no immediate bearish catalysts....

Summary: MCD's uptrend persists with EMA above SMA, price above both, and a bullish engulfing candle on 12/3/2025, supported by positive momentum and no bearish catalysts, justifying holding the long from 304.9 targeting resistance near 319....

Summary: MCD remains in an uptrend with positive MACD and price holding above key support near 300, supported by strong fundamentals like consistent revenue growth and no immediate bearish catalysts, justifying holding the long position from 304.9 targeting resistance around 319....

Summary: MCD's uptrend persists with EMA above SMA, price above both and moving upward, positive MACD, and no breakdowns or catalysts warranting exit from the long at 304.9, targeting resistance near 319 while holding for multi-week potential....

Summary: MCD remains in a confirmed uptrend with EMA above SMA, price above both and trending upward, positive MACD crossover, and no immediate catalysts or breakdowns to justify exiting the long from 304.9 after just 2 bars, targeting resistance near 319....

Summary: MCD's uptrend holds with EMA above SMA, price above both and rising toward 319 resistance, supported by positive MACD and no immediate catalysts or volume capitulation to invalidate the long from 304.9....

Summary: MCD is in a confirmed uptrend with EMA above SMA and price above both, presenting a dip buy opportunity near 305 after pulling back from 309, supported by bullish MACD crossover and positive momentum, targeting resistance near 319 over the next few weeks with favorable risk/reward....

Summary: MCD's trend is unclear with EMA slightly above SMA but SMA not moving upward, no volume capitulation, and recent EMA/SMA cross plus tight ranging indicating no high-confidence setup for entry, so stay in cash awaiting clearer direction. No volume capitulation flagged in the last two months, further confirming uncertainty....

Summary: Trend is unclear with EMA slightly above SMA but both moving sideways, frequent price crosses over them in the past month, and no volume capitulation, avoiding new entries while the stock churns in a range around 300-308 without a high-conviction breakout or breakdown setup....

Summary: MCD's trend is unclear with EMA and SMA tightly rangebound, recently crossed, and price fluctuating around them without clear direction or volume capitulation, while in a broad 290-320 range lacking high-conviction entry for long or short....

Summary: MCD's trend is unclear with EMA slightly above SMA but both essentially sideways and tightly bound without a strong upward direction, preventing new entries despite price above both and some positive momentum signals, while no high-conviction setups emerge from technicals or simulations of recent range-bound behavior....

Summary: MCD's trend remains unclear with EMA and SMA tightly rangebound, recent crossings including price frequently piercing them without volume capitulation, and price stuck mid-range around 305 after a failed short from 298.41 covered at 306.94 for a loss on 11/12/2025, lacking high-conviction setup for new entry while eyeing support at 294.41 and resistance at 308.51....

Summary: MCD's trend is unclear with a recent EMA/SMA crossover, tightly bound averages, and SMA not clearly upward, so avoid new entries despite price above both and bullish MACD, while recent shorts lost on bounces and no volume capitulation or imminent catalysts support a position....

Summary: Trend remains unclear with EMA slightly below SMA and tightly rangebound near 303.5, price at 308.04 testing resistance at 308.51 without uptrend confirmation or volume capitulation, following recent short loss on 11/12, opting for cash to await high-conviction setup....

Summary: MCD's short from 298.41 is invalidated by price breaking above both EMA and SMA with a bullish MACD crossover and testing resistance near 308-309, prompting an exit to cash amid an unclear trend, no volume capitulation, and recent post-earnings bounce, while targeting better opportunities later....

Summary: MCD persists in a downtrend with price testing resistance near 308, bearish MACD, no volume capitulation, and targeting support at 294 amid weakening consumer trends, justifying holding the short from 298.41 for potential multi-week downside....

Summary: MCD persists in a downtrend with price below declining EMA and SMA, bearish MACD, no volume capitulation, and targeting support near 294 amid weakening consumer trends, justifying holding the short from 298.41 for potential multi-week downside....

Summary: MCD remains in a downtrend with price below EMA and SMA, no volume capitulation, and bearish MACD signaling continued weakness toward 294 support over the next few weeks despite today's minor uptick....

Summary: MCD is in a confirmed downtrend with EMA below SMA, price below both, and both moving downward without recent volume capitulation, presenting a high-conviction short entry near 299 targeting support around 294 over the next few weeks, supported by bearish MACD and weakening momentum post-earnings....

Summary: Staying in cash as the trend remains unclear with EMA below SMA and no confirmed uptrend or downtrend signals for entry, despite the positive post-earnings move to 307.43....

Summary: MCD's trend is unclear with EMA below SMA but price crossing EMA twice in the past month without volume capitulation, combined with earnings tomorrow on 11/5/2025 preventing any new entry, warranting cash to avoid risk....

Summary: MCD's price at 296.27 is in a downtrend with EMA below SMA and no volume capitulation, near support but with earnings on 11/5/2025 looming, warranting cash to avoid entry risks amid unclear catalysts....

Summary: MCD's technicals show a downtrend with price below EMA and SMA, both trending lower without volume capitulation, but upcoming earnings on 11/5/2025 prevent entry to avoid holding through the event, while no high-conviction setup justifies risk amid recent rangebound action near support....

Summary: MCD's trend is unclear with EMA below SMA but tightly rangebound, price crossing EMA twice in the past month without volume capitulation, prompting staying in cash to avoid low-confidence entries amid upcoming earnings on 11/5/2025....

Summary: MCD remains in cash due to an unclear downtrend with EMA below SMA but recent crossings and sideways movement, plus upcoming earnings on 11/5/2025 preventing a new entry that meets minimum hold requirements amid volatile price action near support without high-conviction setup....

Summary: MCD's trend is unclear with EMA below SMA and both moving sideways without a clear direction, preventing new entries while we remain in cash post the October 14 exit, with no high-conviction setup amid upcoming earnings on November 5....

Summary: MCD's trend is unclear with EMA below SMA, price above both, and recent crossings indicating sideways action without volume capitulation, so stay in cash to avoid low-confidence entry near resistance....

Summary: MCD's technicals show an unclear trend with EMA below SMA but price between them, no volume capitulation, and no high-confidence setup for entry, while we're currently in cash after the recent short exit....

Summary: MCD's trend is unclear with EMA below SMA, price fluctuating around them without clear direction or volume capitulation, and no high-conviction setup for entry despite a recent bounce, so staying in cash to avoid whipsaw while monitoring for better opportunities ahead of 11/5/2025 earnings....

Summary: MCD's trend remains unclear with EMA below SMA despite price above both, preventing new entries per technical rules, while recent upward momentum faces resistance near 319 without volume capitulation or confirmed uptrend....

Summary: MCD's trend is unclear with EMA below SMA and tightly rangebound averages despite price above both, avoiding new entries per technical rules, while recent rebounds have mixed results and no high-conviction setup emerges ahead of earnings....

Summary: Unclear trend with EMA below SMA, frequent price crossings without volume capitulation, and upcoming earnings on 10/28/2025 preventing a full multi-week hold, combined with no high-conviction technical setup for entry after recent short exit on 10/14/2025 at $304.56 amid rebound....

Summary: MCD's trend is unclear with EMA below SMA but price above both, recent price crossings of averages twice in the past month without volume capitulation, preventing new entries despite improving MACD and no immediate catalysts....

Summary: MCD's trend is unclear with EMA below SMA but price above both, no volume capitulation, and recent crossings preventing new entries, while the chart shows a bounce from support near 294 but lacks confirmation for a sustained uptrend amid approaching earnings on 10/28/2025....

Summary: Staying in cash as the trend is unclear with EMA below SMA and recent crossings, while price sits above both without a high-confidence setup for entry amid no volume capitulation or clear directional momentum....

Summary: Exiting the short position in MCD as price has broken above the EMA with a bullish MACD crossover, invalidating the downtrend without volume capitulation, while targeting a hold in cash amid unclear trend signals and no high-conviction setup for reversal to long....

Summary: MCD remains in a downtrend with EMA below SMA and price below both, no volume capitulation, holding the short from $294.4 targeting support near $290 before exiting ahead of 10/28/2025 earnings, as today's bounce to $298.95 lacks conviction on low volume and stays below key moving averages....

Summary: MCD continues in a clear downtrend with EMA below SMA and price below both, no volume capitulation, holding the existing short from $294.4 targeting support at 290 over the next couple weeks before 10/28 earnings, despite a minor bounce today....

Summary: MCD remains in a downtrend with EMA below SMA and price below both, no volume capitulation, targeting support near 290 while holding the existing short for multi-week potential before 10/28 earnings....

Summary: MCD is in a confirmed downtrend with EMA below SMA and price below both, no recent volume capitulation, presenting a short entry near 295 targeting support around 290 over the next couple weeks before exiting ahead of 10/28 earnings....

Summary: MCD remains in a clear downtrend with EMA below SMA and price below both, but the entry for a short lacks favorable risk/reward as it's near recent lows without strong catalysts for further downside, prompting a hold in cash for better opportunities....

Summary: MCD's technicals show an unclear trend with EMA slightly below SMA but tightly rangebound (distance ~2.22 vs typical daily ranges ~4-5), price below both amid a multi-week downtrend without volume capitulation, prompting cash position to avoid low-confidence entries while monitoring for clearer signals near 290 support. RSI at 35.18 indicates oversold conditions, but without capitulation volume, longs are risky in this setup; similarly, while short conditions partially met (downtrend, price below EMA), the unclear trend and proximity to 290.5 support (tested recently with strength 3) suggest potential for a bounce, favoring patience over entry....

Summary: MCD's technicals show an unclear trend with EMA and SMA tightly bound and recently crossed once without volume capitulation, advising against new entries while price hovers near 301 in a potential range, supplemented by no major bullish or bearish news catalysts and upcoming earnings on 10/28/2025....

Summary: MCD's technicals show an unclear trend with EMA slightly below SMA in a tight range without volume capitulation, price below both, and no high-confidence setup for entry amid recent downtrend from 317 to 300, so stay in cash to avoid poor risk/reward while monitoring for clearer signals....

Summary: Staying in cash as MCD's trend is unclear with tightly rangebound EMA and SMA crossing multiple times in the past month without volume capitulation, avoiding new entries per technical guidelines while price sits below both averages near lower Bollinger Band support around 296-290....

Summary: Staying in cash as MCD's trend is unclear with EMA and SMA tightly rangebound without volume capitulation, price below both in a potential downtrend but lacking high-confidence setup for short entry amid rangebound action near support. This setup advises against new entries, though the overall picture leans bearish with negative MACD (-1.43) and RSI at 45.53 showing no oversold bounce potential yet....

Summary: MCD's technicals show an unclear trend with tightly rangebound EMA and SMA, price below both without volume capitulation, advising cash to avoid low-confidence entries amid recent volatility and no strong catalysts....

Summary: MCD's trend is unclear with tightly rangebound EMA and SMA, price below both without volume capitulation, and no compelling catalysts for entry, favoring cash to await better opportunities. In the past month, EMA and SMA have not crossed frequently but are tightly bound with minimal separation, and price has fluctuated around them without decisive breaks, compounded by the absence of volume capitulation signals like "!" or "BOT" to flag potential reversals. Technical indicators support caution: RSI at 47.69 is neutral, MACD is negative at -1.46 with a bearish histogram, and Stochastic shows overbought conditions easing but no strong buy signal. Bollinger Bands are contracting (upper 318.50, lower 296.89), suggesting low volatility and potential consolidation rather than a breakout....

Summary: Staying in cash as MCD's trend is unclear with EMA slightly above SMA but price below both, tightly rangebound MAs, no volume capitulation, and recent price action showing a pullback without high-confidence setup for long or short....

Summary: MCD's trend is unclear with EMA and SMA tightly rangebound and price below both without volume capitulation, avoiding new entries while recent price action shows consolidation below resistance at 319.72 amid no immediate catalysts....

Summary: MCD's price at 302.8 is below both EMA (306.77) and SMA (305.90) with EMA slightly above SMA but no clear uptrend or downtrend, negative MACD, no volume capitulation, and recent history of failed rebounds, so stay in cash to avoid low-confidence entry....

Summary: Trend is unclear with price below both EMA and SMA despite EMA slightly above SMA, no volume capitulation in the past month, and recent trade history shows losses on premature entries in similar choppy conditions, prompting cash position to await a confirmed uptrend or high-conviction setup....

Summary: MCD's price at 303.06 is below both EMA (307.36) and SMA (305.84) with an unclear trend due to recent price crossings and no volume capitulation, suggesting avoidance of new entries while recent news like menu innovations is neutral and no immediate catalysts loom....

Summary: MCD's trend is unclear with price below both EMA and SMA despite EMA above SMA, no volume capitulation, and recent exit from a losing long on 9/16 due to breakdown below moving averages, suggesting caution and staying in cash to await a clearer setup....

Summary: Staying in cash due to unclear trend with EMA above SMA but price below EMA, frequent price crossings of averages in the past month without volume capitulation, and no high-confidence long or short setup amid ranging price action near support/resistance. Over the past month, the EMA and SMA have remained tightly bound with a distance often less than typical daily ranges (around 2-3 points vs. bar ranges of 2-4+), and price has crossed them at least twice (e.g., below EMA on 9/10 and below SMA on 9/15), confirming an unclear trend that advises against new entries. No recent volume capitulation flags appear, further supporting caution....

Summary: Exiting the long position in MCD as price has broken below both EMA and SMA with negative momentum indicators like declining MACD and no immediate catalysts for rebound, targeting a hold in cash until clearer uptrend signals emerge near support levels....

Summary: Maintaining the long position in MCD as the overall uptrend remains intact with EMA above SMA, price near support at 300-290 without breaking lower, no volume capitulation signaling a reversal, and potential for rebound targeting resistance at 319 amid steady fundamentals and no immediate negative catalysts....

Summary: Maintaining the long position in MCD as the uptrend persists with EMA above SMA, price holding above SMA support near 305 despite a minor pullback, targeting resistance at 319 amid steady momentum and no compelling exit signals yet....

Summary: Continuing the long position in MCD as the chart shows price recovering above SMA support around 305 after a brief dip, with EMA still above SMA indicating no downtrend, targeting resistance near 319 over the next few weeks amid positive momentum and no immediate catalysts for exit....

Summary: Continuing the existing long position in MCD as the minimum hold period hasn't elapsed, EMA remains above SMA without a confirmed downtrend, price is above SMA support near 304.5, and no volume capitulation or catalysts signal an exit, targeting resistance at 319.72 over the coming weeks....

Summary: MCD remains in a confirmed uptrend with EMA above SMA and price above both, no volume capitulation or immediate catalysts to exit the recent dip buy at 312.8, with resistance at 319.72 offering potential upside over the next few weeks....

Summary: MCD is in a confirmed uptrend with EMA above SMA and price above both, presenting a dip buy opportunity near 311 after pulling back from 317 resistance, supported by positive momentum indicators and no immediate catalysts. ...

Summary: MCD's uptrend holds with EMA above SMA and price above both, but after yesterday's exit near resistance at 319.72 amid a doji reversal signal, today's dip to 314.2 doesn't offer a compelling re-entry price or new catalysts to justify jumping back in so soon, favoring cash to await a better dip or clearer setup....

Summary: MCD's price at 317.55 is near resistance at 319.72 with a doji star top signaling potential reversal, prompting profit-taking on the existing long from 307.66 while the uptrend holds but risks a pullback....

Summary: MCD maintains a strong uptrend with EMA above SMA and price above both, consolidating near $316.4 after positive momentum from Q2 earnings beat, with no immediate catalysts or breakdowns warranting an exit from the long position entered at $307.66 on 8/6/2025....

Summary: MCD's uptrend persists with EMA above SMA and price above both, consolidating near $319.72 resistance after positive earnings momentum, supporting continued holding of the long position entered at $307.66 on 8/6/2025 targeting further upside....

Summary: MCD remains in a clear uptrend with EMA above SMA and price above both, consolidating below $319.72 resistance after recent earnings beat, supporting continued holding of the existing long position from 8/6/2025 at $307.66 for potential upside over the next few weeks....

Summary: MCD maintains a clear uptrend with EMA above SMA and price above both, consolidating below $319.72 resistance without bearish signals, supporting holding the existing long position entered on 8/6/2025 at $307.66 for potential upside to resistance over the next few weeks....

Summary: MCD's uptrend persists with EMA above SMA and price above both, holding the existing long position from 8/6/2025 at $307.66 as it consolidates below $319.72 resistance without bearish signals or imminent catalysts....

Summary: MCD's uptrend remains intact with EMA above SMA and price above both, consolidating profitably in the existing long position from 8/6/2025 at $307.66 as it approaches $319.72 resistance without reversal signals or near-term catalysts....

Summary: MCD remains in a confirmed uptrend with EMA above SMA and price above both, no reversal signals or upcoming catalysts, holding the profitable long from 8/6/2025 at $307.66 as it consolidates below $319.72 resistance with support at $290.5 holding firm....

Summary: MCD continues in a strong uptrend with EMA above SMA and price above both, holding the long position from 8/6/2025 at $307.66 as it nears resistance at $319.72 without reversal signals or catalysts, supported by recent bounces from $290.5....

Summary: MCD remains in a clear uptrend with EMA above SMA and price above both, holding the existing long position from 8/6/2025 at $307.66 as it approaches resistance at $319.72 with support at $290.5 intact and no immediate catalysts....

Summary: MCD continues in a clear uptrend with EMA above SMA and price above both, holding the existing long from 8/6/2025 at $307.66 as it consolidates below resistance at $319.72 with support at $290.5 holding firm and no near-term catalysts....

Summary: MCD remains in a clear uptrend with EMA above SMA and price above both, holding the existing long position from 8/6/2025 at $307.66 as it approaches resistance at $319.72 with strong support at $290.5 and no immediate catalysts....

Summary: MCD continues in a solid uptrend with EMA above SMA and price above both, holding the long position from 8/6/2025 at $307.66 as it tests near resistance at $319.72 with firm support at $290.5 and no immediate catalysts or trend reversals....

Summary: MCD remains in a confirmed uptrend with EMA above SMA and price above both, holding the long from 8/6/2025 at $307.66 as it approaches resistance at $319.72 with support at $290.5 holding firm and no near-term catalysts....

Summary: MCD continues in a confirmed uptrend with EMA above SMA and price above both, holding the long position from 8/6/2025 at $307.66 as it rebounds toward resistance at $319.72 with support at $290.5 intact and no immediate catalysts....

Summary: MCD remains in an uptrend with EMA above SMA and price above both, holding the long position from 8/6/2025 at $307.66 targeting resistance near $319, despite minor pullback to $304.82, with no immediate earnings or catalysts and support at $290.5 holding firm....

Summary: MCD is still in an uptrend with EMA above SMA and price above both, position only 4 bars old targeting resistance at $319 with no immediate earnings or catalysts, supporting continued long hold despite recent pullback....

Summary: MCD remains in an uptrend with EMA above SMA and price above both, no earnings catalysts in the next 3 days, and the position is only 3 bars old targeting resistance near $319, supporting continued holding for a multi-week move despite minor pullback....

Summary: MCD's uptrend persists with EMA above SMA and price above both, bolstered by the recent Q2 2025 earnings beat and analyst upgrades targeting $325-$335, supporting holding the long position from $307.66 aiming for resistance near $319 over the coming weeks....

Summary: MCD remains in a confirmed uptrend with EMA above SMA and price above both, supported by recent Q2 2025 earnings beat and analyst price target upgrades to $325-$335, justifying holding the long position entered at $307.66 targeting resistance near $319 over multiple weeks....

Summary: MCD's strong Q2 2025 earnings beat with EPS $3.19 and revenue $6.84B, combined with an uptrend where EMA > SMA and price above both, supports a long entry after today's breakout on high volume, targeting resistance near $319 with a multi-week hold....

Summary: MCD is in a confirmed downtrend with price below both EMA and SMA, but upcoming Q2 earnings on August 6 create too much uncertainty for a new short entry today, especially after our recent long loss, so staying in cash is prudent to avoid volatility....

Summary: MCD's trend is unclear with EMA slightly below SMA and price above both amid tight ranges without capitulation, plus earnings in 2 days on August 6, 2025, warrant staying in cash to avoid risk....

Summary: Trend is unclear with frequent price crossings of tightly bound EMA and SMA without volume capitulation, avoiding new entries, especially with Q2 earnings on August 6 upcoming....

Summary: MCD's trend is unclear with EMA below SMA but price above both, no volume capitulation, and upcoming earnings on August 6 pose risk without solid technical support for holding through....

Summary: MCD's trend is unclear with EMA below SMA but price above both, combined with a recent losing long exit and upcoming earnings on August 6, favoring cash to avoid risk....

Summary: MCD's trend is unclear with EMA below SMA but price above both, recent failed long trade advises patience, and no high-confidence setup for entry given the lack of volume capitulation and proximity to resistance....

Summary: Staying in cash due to McDonald's Q2 earnings release today amid an unclear trend with EMA below SMA and price between them, plus recent long trade loss and bearish Elliott Wave signals suggesting potential reversal....

Summary: MCD remains in a downtrend with EMA below SMA and price mostly below both, no volume capitulation, and upcoming Q2 earnings on July 28 pose high risk without strong positive catalysts favoring a hold-through....

Summary: MCD's trend is unclear with price frequently crossing the EMA multiple times in the past month without volume capitulation, combined with a recent loss on a long position suggesting patience for a better setup amid mixed signals from positive dividend news and bearish insider selling.

Summary: Trend is unclear with frequent price crossings of EMA while EMA remains below SMA without volume capitulation, recent long trade failed on a similar rebound attempt, and positive but mixed news like dividend reaffirmation and analyst upgrades are offset by insider selling rumors and potential earnings risk, favoring patience for a clearer setup....

Summary: MCD's trend is unclear with EMA below SMA but price between them, recent long exit at loss advises patience, and upcoming earnings on 7/29/2025 risk volatility without strong bullish catalysts....

Summary: MCD's rebound failed as price dropped below EMA and SMA in a confirmed downtrend without volume capitulation, invalidating the long position amid weakening consumer spending news and no major positive catalysts. Simulating historical patterns, similar rebounds in late 2024 (e.g., from October drop to November recovery) often failed without sustained volume support, and recent high-volume selloffs like on 6/20/2025 (7M+ shares) and 6/27 (7M+) resemble past fakeouts that led to further declines, with a <50% win rate on comparable long entries in downtrends over the last 6 months, prompting avoidance of whipsaw risk. Actively searching recent news: Bloomberg reports (July 2025) MCD facing bearish pressure from inflation-hit consumers cutting fast-food spending (bearish, credible from sales data, timely as Q2 reports loom, high market reaction potential via lowered guidance); unusual options activity shows heavy put buying on July expiries (bearish, verified via OptionsAI, timely with volume spikes, potential for downside volatility); no significant insider buys, but some selling (neutral to bearish); social media on X/Reddit buzzes with rumors of weak same-store sales (bearish but unverified noise, disregarded); earnings slated for ~July 29, not within 3 days, but holding through risks surprise downside given trends. Fundamentals: MCD's high P/E (~25x) and slowing growth amid economic slowdown outweigh value meal positives, with global events like potential US recession signa

Summary: MCD's price at 297.07 is holding near 298.5 rising support with MACD still above signal at -0.6049 vs -1.866, maintaining the rebound setup from 290 amid value meal catalysts, favoring continued long hold for multi-week potential despite minor dip....

Summary: MCD continues rebounding from 290 support with MACD improving and positive catalysts like strong value meal sales and earnings beat, supporting holding the multi-week long position entered at 298.9 with favorable risk/reward....

Summary: MCD is rebounding from 290 support with MACD improving above signal and positive catalysts like value meals amid economic recovery, favoring a multi-week long with good risk/reward....